Tenaya Therapeutics’ $50 Common Stock Offering

Wilson Sonsini Goodrich & Rosati advised Tenaya Therapeutics on the transaction, and Davis Polk & Wardwell advised the underwriters.Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now